OraSure Technologies Inc., a developer and manufacturer of rapid diagnostic tests, collection, and stabilization devices headquartered in Bethlehem, will expand its manufacturing operations, creating 177 new jobs and retaining 233 jobs. OraSure was one of Ben Franklin Technology Partners’ earliest clients.
“At a time when the Commonwealth is ramping up COVID-19 testing, OraSure Technologies’ expansion will bring both economic opportunities to the region and increased testing accessibility,” said Gov. Wolf. “OraSure Technologies has been a staple in Bethlehem for decades, and my administration is pleased to support their expansion in the Commonwealth.”
OraSure (NASDAQ: OSUR) is developing a rapid antigen self-test that would detect active COVID-19 infection with no need to transport samples to a lab for processing. Individuals would be able to easily self-collect a sample and read the results themselves a short time later. The company intends to submit the “game-changing” antigen test to the U.S. FDA for Emergency Use Authorization, allowing for the rapid self-test to debut into the U.S. market. Via Gov. Tom Wolf, Morning Call, Lehigh Valley Business